Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Astra returns rights to ALX1-11; Allelix to aggressively pursue development

Sep. 25, 1998

More on NPY receptor antagonists developed at Banyu

Sep. 24, 1998

Banyu claims aminopyrazoles for eating disorders, diabetes

Sep. 23, 1998

New data indicate Evista significantly reduces spinal fractures

Sep. 23, 1998

ACAT inhibitor synthesized at Slovakofarma and presented at EFMC symposium

Sep. 21, 1998

Pfizer identifies glycogen phosphorylase inhibitor as potent antidiabetic agent

Sep. 21, 1998

Ixion's method of producing islet cells to be covered by U.S. patent

Sep. 21, 1998

Baxter refocuses blood substitute program

Sep. 17, 1998

Nasal calcitonin reduces spinal fractures in postmenopausal women with osteoporosis

Sep. 17, 1998

Novo files for U.S. marketing approval of insulin analogue

Sep. 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...